home / stock / igms / igms articles

IGMS Articles, IGM Biosciences Inc. - From 02/09/24

Stock Information
Company Name: IGM Biosciences Inc.
Stock Symbol: IGMS
Market: NYSE
Website: igmbio.com
Menu
IGMS IGMS Quote IGMS Short IGMS News IGMS Articles IGMS Message Board
Get IGMS Alerts

News, Short Squeeze, Breakout and More Instantly...
SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ: SPSC) rose sharply ...
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference | Benzinga

MOUNTAIN VIEW, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ:IGMS), a clinical-stage biotechnology company creating an...

Morgan Stanley Reports Q4 Results, Joins Boeing, Alcoa And Other Big Stocks Moving Lower On Tuesday | Benzinga

U.S. stocks traded lower, with the Dow Jones index falling more than 250 points on Tuesday. Shares of Morgan Stanley (NYSE: MS) fell during Tuesda...

Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday. Shares of Acuity Brands, Inc. (NYSE: AYI) rose sharply Tuesd...
IGM Biosciences Increases Focus On Autoimmune Diseases, Stops All Blood Cancer-Related Studies | Benzinga

IGM Biosciences Inc (NASDAQ: IGMS) said it will focus on two strategic areas: treating colorectal cancer using IgM death receptor 5 (DR5) agon...

IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension | Benzinga

– Priorities: clinical development of DR5 agonist in colorectal cancer and T cell engagers in autoimmune disease – – Plans to file IND for I...

IGM Biosciences to Present at Two Upcoming Investor Conferences | Benzinga

MOUNTAIN VIEW, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ:IGMS), a clinical-stage biotechnology company focused on ...
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Arge...

IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors | Benzinga

MOUNTAIN VIEW, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ:IGMS), a clinical-stage biotechnology company focused on ...

IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference | Benzinga

MOUNTAIN VIEW, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) --  IGM Biosciences, Inc. (NASDAQ:IGMS), a clinical-stage biotechnology company focused ...
Previous 10 Next 10